VelaDx to Launch CE-IVD Marked NGS Workflow with Clinical Assays on PGM this Summer | GenomeWeb

NEW YORK (GenomeWeb) – VelaDx this year plans to launch next-generation sequencing workflows on Life Technologies' Ion Torrent PGM platform with CE-IVD oncology and virology assays.

The company will market and sell the entire workflow, which includes the PGM system, its Sentosa SX101 automation platform, necessary reagents for specific assays, and bioinformatics, as a "turnkey solution" for clinical customers, VelaDx CEO Michael Tillman told Clinical Sequencing News.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.